• Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
Search
Medicines Law & Policy Research and resources on intellectual property and health
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About

Medicines Law & Policy

21 POSTS 0 COMMENTS

Wrapping up 2022 with some noteworthy medicines, law and policy events

Medicines Law & Policy - December 22, 2022

Seven recommendations for sharing intellectual property, know-how and technology – report of Global Expert...

Medicines Law & Policy - July 18, 2022

WTO Covid-19 TRIPS Decision: Some observations

Medicines Law & Policy - June 17, 2022

Proposed TRIPS waiver a hollow diplomatic compromise with little practical impact

Medicines Law & Policy - April 12, 2022

The US NIH will share technology with WHO to fight the pandemic

Medicines Law & Policy - March 3, 2022

A second Covid-19 treatment will now be made available through the Medicines Patent Pool

Medicines Law & Policy - November 16, 2021

Medicines Patent Pool signs first Covid-19 licence agreement with Merck Sharp & Dohme. Others...

Medicines Law & Policy - October 27, 2021

The EU proposed Covid waivers of certain TRIPS rules are mostly meaningless

Medicines Law & Policy - October 14, 2021

Advanced Purchase Agreements for Covid-19 Vaccines: Do they ensure Global Public Good?

Medicines Law & Policy - July 21, 2021

US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a...

Medicines Law & Policy - May 6, 2021
123Page 1 of 3
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
 This work is licensed under Creative Commons.